SCHEMBL114572

SCHEMBL114572

COc1ncc(-c2cc(F)ccc2N2CCN(C(C=O)n3nc(C)cc3C)CC2)cn1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.33
ABL1 P00519 1/20 0.33
TNIK Q9UKE5 1/20 0.32
DPP4 P27487 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP9 Q86TI2 1/20 0.32
DPP7 Q9UHL4 1/20 0.32
SCD O00767 1/20 0.32
HTR1A P08908 1/20 0.32
HTR7 P34969 1/20 0.32
TSHR P16473 2/20 0.32
KMO O15229 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
PIK3CA P42336 1/20 0.32
ACVR1 Q04771 1/20 0.31
CXCR3 P49682 1/20 0.31
TNK2 Q07912 1/20 0.31
KIT P10721 1/20 0.31
NPY2R P49146 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113054 0.90 TNIK (0.34) DHFRABL1TNIKALDH1A1MAPK7
SCHEMBL114717 0.90 ABL1 (0.34) DHFRABL1TNIKTSHRCXCR3
SCHEMBL114268 0.89 CXCR3 (0.40) DHFRHTR1AHTR7TSHRPIK3CA
SCHEMBL113998 0.85 AOC3 (0.39) TNIKPIK3CALRRK2
SCHEMBL114135 0.80 CXCR3 (0.41) HTR1AHTR7ALDH1A1CXCR3TNK2
SCHEMBL113245 0.80 AGER (0.36) DHFRABL1HTR1AHTR7CYP1A2
SCHEMBL113540 0.79 CXCR3 (0.40) DHFRHTR1AHTR7TSHRALDH1A1
SCHEMBL115477 0.79 CXCR3 (0.42) DHFRHTR1AHTR7TSHRCXCR3
SCHEMBL115324 0.78 KCNH2 (0.41) SCDHTR1AHTR7PIK3CACXCR3
SCHEMBL114798 0.78 KDR (0.38) DHFRTNIK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed